Are you saying the NIH process is corruptible?
I think you are drawing a long bow here.
NIH chose Imm124 as one of three products after reviewing the merits of a vast number, so clearly that was validation.
Not sure the NIH would expose itself in the way you have described above.
Ann: Appendix 4D - Half Yearly Report and Accounts, page-17
Add IMC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
-0.005(4.76%) |
Mkt cap ! $22.79M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.0¢ | $18.24K | 181.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 133830 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 166666 | 3 |
View Market Depth
| Last trade - 12.45pm 01/10/2024 (20 minute delay) ? |
| IMC (ASX) Chart |